Synergistic Effects of the Combinational Use of Escitalopram Oxalate and 5-Fluorouracil on the Inhibition of Gastric Cancer SNU-1 Cells

Owing to its high recurrence rate, gastric cancer (GC) is the leading cause of tumor-related deaths worldwide. Besides surgical treatment, chemotherapy is the most commonly used treatment against GC. However, the adverse events associated with chemotherapy use limit its effectiveness in GC treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Vincent Chin-Hung, Huang, Jing-Yu, Tzang, Bor-Show, Hsu, Tsai-Ching, McIntyre, Roger S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781210/
https://www.ncbi.nlm.nih.gov/pubmed/36555820
http://dx.doi.org/10.3390/ijms232416179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781210/
https://www.ncbi.nlm.nih.gov/pubmed/36555820
http://dx.doi.org/10.3390/ijms232416179

Ejemplares similares